These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

401 related articles for article (PubMed ID: 26125447)

  • 1. Cell-free DNA levels in plasma of patients with non-small-cell lung cancer and inflammatory lung disease.
    Szpechcinski A; Chorostowska-Wynimko J; Struniawski R; Kupis W; Rudzinski P; Langfort R; Puscinska E; Bielen P; Sliwinski P; Orlowski T
    Br J Cancer; 2015 Jul; 113(3):476-83. PubMed ID: 26125447
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Plasma cell-free DNA levels and integrity in patients with chest radiological findings: NSCLC versus benign lung nodules.
    Szpechcinski A; Rudzinski P; Kupis W; Langfort R; Orlowski T; Chorostowska-Wynimko J
    Cancer Lett; 2016 May; 374(2):202-7. PubMed ID: 26854716
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Plasma cell-free DNA level and its integrity as biomarkers to distinguish non-small cell lung cancer from tuberculosis.
    Leng S; Zheng J; Jin Y; Zhang H; Zhu Y; Wu J; Xu Y; Zhang P
    Clin Chim Acta; 2018 Feb; 477():160-165. PubMed ID: 29113814
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Use of a new generation of capillary electrophoresis to quantify circulating free DNA in non-small cell lung cancer.
    Chiappetta C; Anile M; Leopizzi M; Venuta F; Della Rocca C
    Clin Chim Acta; 2013 Oct; 425():93-6. PubMed ID: 23892142
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Folate Receptor-Positive Circulating Tumor Cell Detected by LT-PCR-Based Method as a Diagnostic Biomarker for Non-Small-Cell Lung Cancer.
    Chen X; Zhou F; Li X; Yang G; Zhang L; Ren S; Zhao C; Deng Q; Li W; Gao G; Li A; Zhou C
    J Thorac Oncol; 2015 Aug; 10(8):1163-71. PubMed ID: 26200270
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The diagnostic value of circulating cell free DNA quantification in non-small cell lung cancer: A systematic review with meta-analysis.
    Jiang T; Zhai C; Su C; Ren S; Zhou C
    Lung Cancer; 2016 Oct; 100():63-70. PubMed ID: 27597282
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Epithelial-specific methylation marker: a potential plasma biomarker in advanced non-small cell lung cancer.
    Vinayanuwattikun C; Sriuranpong V; Tanasanvimon S; Chantranuwat P; Mutirangura A
    J Thorac Oncol; 2011 Nov; 6(11):1818-25. PubMed ID: 21964525
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluating circulating cell-free DNA and DNA integrity index as biomarkers in non-small cell lung cancer.
    Ezzeldin N; El-Lebedy D; Hassan M; Shalaby AO; Hussein SAM; Gharib AM; Hamdy G; Mohammed AM; Ramadan A; Sobeih ME
    J Egypt Natl Canc Inst; 2024 Jun; 36(1):21. PubMed ID: 38880832
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Levels of cell-free DNA and plasma KRAS during treatment of advanced NSCLC.
    Dowler Nygaard A; Spindler KL; Pallisgaard N; Andersen RF; Jakobsen A
    Oncol Rep; 2014 Feb; 31(2):969-74. PubMed ID: 24316734
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serum miR-125a-5p, miR-145 and miR-146a as diagnostic biomarkers in non-small cell lung cancer.
    Wang RJ; Zheng YH; Wang P; Zhang JZ
    Int J Clin Exp Pathol; 2015; 8(1):765-71. PubMed ID: 25755772
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Detection of cancer specific mutations in early-stage non-small cell lung cancer using cell-free DNA by targeted sequencing.
    He Y; Zhang X; Wang L; Tian Z; Liu Q; Yao J; Liu Y; Li C; Min L; Shan B
    Int J Oncol; 2016 Dec; 49(6):2351-2358. PubMed ID: 27748796
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Diagnostic significance of S100A2 and S100A6 levels in sera of patients with non-small cell lung cancer.
    Wang T; Liang Y; Thakur A; Zhang S; Yang T; Chen T; Gao L; Chen M; Ren H
    Tumour Biol; 2016 Feb; 37(2):2299-304. PubMed ID: 26361956
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Combined identification of long non-coding RNA XIST and HIF1A-AS1 in serum as an effective screening for non-small cell lung cancer.
    Tantai J; Hu D; Yang Y; Geng J
    Int J Clin Exp Pathol; 2015; 8(7):7887-95. PubMed ID: 26339353
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serum reactive oxygen species modulator 1 (Romo1) as a potential diagnostic biomarker for non-small cell lung cancer.
    Lee SH; Lee JS; Lee EJ; Min KH; Hur GY; Lee SH; Lee SY; Kim JH; Lee SY; Shin C; Shim JJ; Kang KH; In KH
    Lung Cancer; 2014 Aug; 85(2):175-81. PubMed ID: 24951318
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cell-free DNA as a prognostic marker in stage I non-small-cell lung cancer patients undergoing stereotactic body radiotherapy.
    Bortolin MT; Tedeschi R; Bidoli E; Furlan C; Basaglia G; Minatel E; Gobitti C; Franchin G; Trovò M; De Paoli P
    Biomarkers; 2015; 20(6-7):422-8. PubMed ID: 26526078
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Quantitative analysis of free-circulating DNA in plasma of patients with resectable NSCLC.
    Szpechcinski A; Chorostowska-Wynimko J; Kupis W; Maszkowska-Kopij K; Dancewicz M; Kowalewski J; Orlowski T
    Expert Opin Biol Ther; 2012 Jun; 12 Suppl 1():S3-9. PubMed ID: 22559166
    [TBL] [Abstract][Full Text] [Related]  

  • 17. miR-1254 and miR-574-5p: serum-based microRNA biomarkers for early-stage non-small cell lung cancer.
    Foss KM; Sima C; Ugolini D; Neri M; Allen KE; Weiss GJ
    J Thorac Oncol; 2011 Mar; 6(3):482-8. PubMed ID: 21258252
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [OLC1 protein levels in plasma of patients with non-small cell lung cancer and its clinical application].
    Yang L; Xiao T; Tan J; Chen S; Gao Y; Cheng S; Liu X; Sun K
    Zhonghua Zhong Liu Za Zhi; 2014 May; 36(5):362-5. PubMed ID: 25030592
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serum miR-499 as a novel diagnostic and prognostic biomarker in non-small cell lung cancer.
    Li M; Zhang Q; Wu L; Jia C; Shi F; Li S; Peng A; Zhang G; Song X; Wang C
    Oncol Rep; 2014 Apr; 31(4):1961-7. PubMed ID: 24549225
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Aberrant reduction of telomere repetitive sequences in plasma cell-free DNA for early breast cancer detection.
    Wu X; Tanaka H
    Oncotarget; 2015 Oct; 6(30):29795-807. PubMed ID: 26356673
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.